Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

XDx

- PMLiVE

Biogen appoints executive VP, corporate development

Daniel Karp will also become a member of the executive committee

- PMLiVE

Exelixis appoints Andrew Peters to newly created position

He joins the biotech as its vice president, strategy

- PMLiVE

Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report

Orphan drug sales growth will be 11%+ a year

Lucid bolsters client services and delivery teams

Helen Hutton, David Burton and Clare Bibby join the agency

- PMLiVE

Novartis bribery probe in Greece ‘could affect general election’

The pharma giant allegedly gave “bundles of cash” to civil servants, doctors and politicians

- PMLiVE

Axovant poaches Allergan’s and Teva’s chief medical and science officers

Gavin Corcoran and Michael Hayden join the biopharma

Sue Mahony to retire as president of Lilly Oncology

She will continue in her position until August 31

- PMLiVE

The Difference Collective boosts its creative and media offerings

Stuart Mayell and Jo Willey join the group

- PMLiVE

Kevin Sin joins GSK

He becomes senior VP, head of worldwide business development

- PMLiVE

ICER says price of Amgen/Novartis’ Aimovig is OK – if used last-line

Recommends the drug should only be used in patients who have exhausted other prevention options

Abeona Therapeutics appoints new additions to board of directors

Stefano Buono and Richard Van Duyne join the biopharma

- PMLiVE

Prevail Therapeutics adds to its board of directors

Francois Nader joins the biotech

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links